Patents by Inventor Karl-Heinz Klingler

Karl-Heinz Klingler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5405847
    Abstract: Novel compounds of the formula ##STR1## where the phenyl ring can also contain a nitrogen atom instead of a CH group, R.sub.1 is C.sub.2 -C.sub.6 -alkenyl, C.sub.2 -C.sub.6 -alkynyl, hydroxy, C.sub.1 -C.sub.6 -alkoxy, C.sub.3 -C.sub.6 -alkenyloxy, C.sub.3 -C.sub.6 -alkynyloxy, C.sub.2 -C.sub.6 -alkanoyloxy, benzoyloxy, morpholinocarbonyloxy, C.sub.1 -C.sub.6 -alkyloxycarbonyloxy, C.sub.1 -C.sub.6 -alkylaminocarbonyloxy, C.sub.1 -C.sub.6 -dialkylaminocarbonyloxy or the group -Alk-A, where Alk represents C.sub.1 -C.sub.6 -alkyl, C.sub.2 -C.sub.6 -hydroxyalkyl or C.sub.3 -C.sub.6 -cycloalkyl and the symbol A represents hydrogen or other substituents.R.sub.2, R.sub.3 and R.sub.4 represent various substituents, where R.sub.1 may also be hydrogen, when R.sub.2 is the group ##STR2## and R.sub.5 represents phenyl, C.sub.1 -C.sub.4 -alkoxyphenyl or diphenylmethyl and R.sub.3 and R.sub.4 are hydrogen and their salts. The compounds provide anti-allergic, anti-asthmatic, anxiolytic and hypotensive effects.
    Type: Grant
    Filed: August 24, 1993
    Date of Patent: April 11, 1995
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Hans-Reinhold Dieter, Jurgen Engel, Karl-Heinz Klingler, Bernhard Kutscher, Stefan Szelenyi, Ute Achterath-Tuckermann, Jurgen Schmidt, Peter Metzenauer
  • Patent number: 4317832
    Abstract: Compounds corresponding to the formula ##STR1## are disclosed, wherein Alk represents a C.sub.2 -C.sub.5 -alkylene groups optionally substituted by a hydroxy group and Ar represent an optionally substituted phenyl, naphthyl, tetrahydronaphthyl, indanyl or indenyl radical or a monocyclic or condensed bicyclic or tricyclic heterocyclic radical which is optionally substituted, the heterocyclic radical consisting of individual rings having 5 or 6 members and optionally containing from 1 to 4 hetero atoms, and the acid addition salts thereof. A process for producing these compounds is also disclosed. These substituted aminoalkyl guanidines block the .beta.-receptors of the adrenergic nerve system, and also reduce blood pressure.
    Type: Grant
    Filed: September 5, 1979
    Date of Patent: March 2, 1982
    Inventors: Karl-Heinz Klingler, Axel Kleemann, Fritz Stroman, Klaus Thiemer
  • Patent number: 4150227
    Abstract: Basic substituted alkyl theophylline derivatives of the formula ##STR1## in which Alk is a straight or branched chain alkylene group with 2 to 4 carbon atoms and R is hydrogen or a methyl group are produced by catalytic hydrogenation of compounds of the formula ##STR2## where the phenolic hydroxyl groups and/or the secondary basic nitrogen atom can contain protective groups using as the solvent a compound of the formula ##STR3## where R', R" and R'" are the same or different and are alkyl groups of 1 to 2 carbon atoms and R' together with R'" can also be an alkylene bridge with 3 to 4 carbon atoms and in a given case the protective groups present are split off.
    Type: Grant
    Filed: December 21, 1977
    Date of Patent: April 17, 1979
    Assignee: Deutsche Gold- und Silber-Scheideanstalt vormals Roessler
    Inventors: Karl-Heinz Klingler, Erich Bickel